Jinsheng Liang

AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas

Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric et al. · Cancer Cell · 2015 · 331 citations · Full text

Oncology, Pi3kα Inhibition, Signaling Pathway +13

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors

Leila Dardaei, Hui Qin Wang, Manrose Singh et al. · Nature Medicine · 2018 · 198 citations · Full text

Alk Inhibitors, Medicine, Pharmacology +8

Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

Sabrina Baltschukat, Barbara Schacher Engstler, Alan Huang et al. · Clinical Cancer Research · 2019 · 171 citations

Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity

Jinsheng Liang, D. Melican, Lauren Cafro et al. · International Journal of Immunopharmacology · 1998 · 136 citations

Inflammation, Oxidative Burst Activity, Health Sciences +10

An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin

Andrew P. Garner, Carl Uli Bialucha, Elizabeth R. Sprague et al. · Cancer Research · 2013 · 121 citations · Full text

Her2/her3 Dimerization, Medicine, Inactive Conformation +12